Recursion Pharmaceuticals (RXRX) Exchange Rate Effect: 2022-2025
Historic Exchange Rate Effect for Recursion Pharmaceuticals (RXRX) over the last 3 years, with Sep 2025 value amounting to $1.9 million.
- Recursion Pharmaceuticals' Exchange Rate Effect rose 363.77% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year increase of 6471.05%. This contributed to the annual value of -$3.4 million for FY2024, which is 1911.70% down from last year.
- As of Q3 2025, Recursion Pharmaceuticals' Exchange Rate Effect stood at $1.9 million, which was down 79.81% from $9.3 million recorded in Q2 2025.
- Recursion Pharmaceuticals' Exchange Rate Effect's 5-year high stood at $9.3 million during Q2 2025, with a 5-year trough of -$3.5 million in Q4 2024.
- Over the past 3 years, Recursion Pharmaceuticals' median Exchange Rate Effect value was $124,000 (recorded in 2023), while the average stood at $1.2 million.
- Per our database at Business Quant, Recursion Pharmaceuticals' Exchange Rate Effect plummeted by 10,850.00% in 2024 and then spiked by 7,943.22% in 2025.
- Recursion Pharmaceuticals' Exchange Rate Effect (Quarterly) stood at -$307,000 in 2022, then skyrocketed by 140.39% to $124,000 in 2023, then plummeted by 2,900.00% to -$3.5 million in 2024, then spiked by 363.77% to $1.9 million in 2025.
- Its Exchange Rate Effect was $1.9 million in Q3 2025, compared to $9.3 million in Q2 2025 and $4.8 million in Q1 2025.